U.K. signs deals with BioNTech, Pfizer, and Valneva for COVID-19 vaccines – MarketWatch

The U.K. Government said on Monday that it has secured early access to 90 million vaccine doses of 2 possible COVID-19 vaccines being developed by a collaboration between Germanys BioNTech and U.S. d. [+2756 chars]